Rama ALkhawaldeh

Ms. Rama ALkhawaldeh


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
RFRana Abu Farha
Rana Abu Farha
KAKarem Alzoubi
Karem Alzoubi
TMTareq Mukattash
Tareq Mukattash
RARama ALkhawaldeh
Rama ALkhawaldeh
Muna BarakatMuna Barakat
Muna Barakat
STSamar Thiab
Samar Thiab
Hundreds of human mpox cases are spreading outside of Western and Central Africa, which could be considered a significant world health problem. In this study, we sought to assess public knowledge and perceptions of human mpox. The study was a cross-sectional survey conducted in Jordan in September–October 2022. All participants were approached through social media portals. A total of 1195 participants agreed to participate in this study. The participants showed a low median knowledge score about human mpox (4.0 out of 15.0, IQR = 5.0), with only 27.9% of the participants (n = 334) correctly identifying that human mpox is not a bacterial disease, and around half of them (n = 589, 49.3%) knowing that this disease affects both genders. Higher monthly income (≥400 JD/month) was significantly associated with better knowledge about the disease. Social media was the most comprehensive source of information about mpox (n = 1018, 85.2%). Finally, 57.3% of the participants (n = 685) believed that mpox would affect social and economic life, like the COVID-19 pandemic. These findings highlight the urgent need for systematic strategies that should be promoted to increase public knowledge of mpox, which will be critical in improving the capacity to respond to the disease.

6 May 2022 in Antibiotics
Verified
Journal Article
Open access
PDF file
RARama ALkhawaldeh
Rama ALkhawaldeh
RFRana Abu Farha
Rana Abu Farha
KHKhawla Abu Hammour
Khawla Abu Hammour
Eman AlefishatEman Alefishat
Eman Alefishat
This is a cross-sectional study that was conducted at Jordan University Hospital (JUH) to evaluate the appropriateness of Urinary Tract Infection (UTI) empiric treatment based on microbial culture data and susceptibility testing. All urine cultures requested for adult patients (≥18 years) admitted to JUH within the period from January 2019–July 2021 were reviewed and only those cultures with positive episodes of infection were considered. In this study, 6950 urine culture episodes were screened; among them, 34.5% (n = 2400) revealed positive results. Among those patients with positive culture episodes, 1600 patients (66.7%) were discharged before the availability of culture results and were excluded. Of the remaining eligible 800 patients, 701 (87.6%) received empiric treatment. In 26.8% of the eligible cases (n = 214), the prescribed empiric agents failed to have appropriate coverage of the identified pathogens, and in 14.6% of the cases (n = 117) the identified microorganisms were reported as resistant to the prescribed empiric agents. Furthermore, only 13.4% of the patients (n = 107) were appropriately treated for their UTI with empiric antibacterial agents. We were not able to judge the appropriateness of UTI treatment for one third (n = 263, 32.9%) of the patients, because they did not have susceptibility reports performed. This study revealed an alarmingly high rate of inappropriate treatment of UTIs, which encourages the emergence of bacterial resistance and affects health-related outcomes negatively. Therefore, antimicrobial stewardship programs must be applied to optimize antibiotic consumption in hospital settings.

Verified
Journal Article
Open access
PDF file
RARama ALkhawaldeh
Rama ALkhawaldeh
LGLobna Gharaibeh
Lobna Gharaibeh
AKAmer Hayat Khan
Amer Hayat Khan
KHKhawla Abu Hammour
Khawla Abu Hammour
MZMohammed Zawiah
Mohammed Zawiah
RFRana Abu Farha
Rana Abu Farha
Objectives: This retrospective analysis was conducted to update the antibiotic sensitivity profiles of Escherichia coli (E. coli) in urinary tract infections (UTIs) among adults (≥18 years) in Jordan. Methods: Data were collected from patients diagnosed with UTIs and confirmed by positive E. coli cultures between 1 January 2019 and 9 July 2021. The resistance patterns of E. coli to empiric antibiotics were assessed by matching the prescribed antibiotics with those tested, using clinical breakpoints to classify isolates as susceptible or resistant. Results: During the study, 230 patients with urine cultures confirming E. coli infection were included. Empiric antibiotics were prescribed to 87.4% (n = 201) of patients. Sensitivity testing was performed for 136 patients (59.1%), revealing that 62 patients (27%) had E. coli strains resistant to at least one antibiotic. Among the 236 empiric antibiotics prescribed, the appropriateness of 72 agents (30.5%) could not be determined owing to the absence of sensitivity testing. The culture results indicate that eight antibiotics (3.3%) did not provide adequate coverage against E. coli. Of the remaining 156 agents (66.1%) subjected to sensitivity testing, 89 (37.7%) were effective, while 67 (28.3%) were ineffective owing to bacterial resistance. Patients who underwent sensitivity tests performed had significantly longer hospital stays (10 days) than those who did not (8 days; p = 0.032). Female patients had a higher proportion of resistant E. coli isolates (51.5%) compared to males (30.8%, p = 0.036). Conclusions: This study highlights the importance of ongoing surveillance to guide empiric therapy and promote appropriate antibiotic use. Tailoring treatment based on patient-specific factors is essential to effectively managing antimicrobial resistance and improving clinical outcomes.